investigational live attenuated mumps vaccine

BIOLOGICAL2 trials

Sponsors

Sinovac (Dalian) Vaccine Technology Co., Ltd., Sinovac Research and Development Co., Ltd.

Conditions

Mumps

Phase 3

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

CompletedNCT02692599

Sinovac (Dalian) Vaccine Technology Co., Ltd.Mumps

Start: 2016-01-31End: 2016-07-15Updated: 2017-10-26

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

CompletedNCT05065177

Sinovac Research and Development Co., Ltd.Mumps

Start: 2016-01-31End: 2016-04-30Updated: 2021-10-01